Table 1.
Clinical and demographic characteristics of the study population stratified by age.
Table 2.
Histopathological characteristics of radical prostatectomy specimens stratified by age.
Fig 1.
ROC curve for the age group ≤ 49 years stratified for fPSA values ≤18% vs. >18% and ≤21% vs. >21%, respectively.
Fig 2.
ROC curve for the age group ≤50–59 years stratified for fPSA values ≤18% vs. >18% and ≤21% vs. >21%, respectively.
Fig 3.
ROC curve for the age group 60–69 years stratified for fPSA values ≤18% vs. >18% and ≤21% vs. >21%, respectively.
Fig 4.
ROC curve for the age group ≥ 70 years stratified for fPSA values ≤18% vs. >18% and ≤21% vs. >21%, respectively.
Table 3.
Proposed “new” PSA cut offs stratified by age.
Table 4.
Comparison of “new” and “old” PSA cut offs concerning specificity (spec), sensitivity (sens) as well as positive (pos pred) and negative predictive (neg pred) values stratified by age.
Table 5.
Recognized tumors (%) biopsied according to “old” PSA cut offs stratified by age.
Table 6.
Recognized tumors (%) biopsied according to “new” PSA cut offs stratified by age.
Table 7.
Reduction of number of biopsies with the “new” PSA cut offs stratified by age.